메뉴 건너뛰기




Volumn 116, Issue 14, 2010, Pages 2617-2618

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DASATINIB; IFOSFAMIDE; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; MITOXANTRONE;

EID: 77957732539     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-279786     Document Type: Letter
Times cited : (14)

References (6)
  • 1
    • 0034662219 scopus 로고    scopus 로고
    • Leukemic meningitis in B-cell chronic lymphocytic leukemia: Resolution following intrathecal methotrexate
    • Marmont AM. Leukemic meningitis in B-cell chronic lymphocytic leukemia: resolution following intrathecal methotrexate. Blood. 2000;96(2):776-777.
    • (2000) Blood , vol.96 , Issue.2 , pp. 776-777
    • Marmont, A.M.1
  • 2
    • 58849162358 scopus 로고    scopus 로고
    • Dasatinib induces a response in chronic lymphocytic leukemia
    • letter
    • Pitini V, Arrigo C, Altavilla G. Dasatinib induces a response in chronic lymphocytic leukemia [letter]. Blood. 2009;113(2):498.
    • (2009) Blood , vol.113 , Issue.2 , pp. 498
    • Pitini, V.1    Arrigo, C.2    Altavilla, G.3
  • 3
    • 67649973505 scopus 로고    scopus 로고
    • Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia
    • Tecchio C, Nichele I, Todeschini G, Pizzolo G, Ambrosetti A. Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia. Br J Haematol. 2009;146(2):222-223.
    • (2009) Br J Haematol , vol.146 , Issue.2 , pp. 222-223
    • Tecchio, C.1    Nichele, I.2    Todeschini, G.3    Pizzolo, G.4    Ambrosetti, A.5
  • 4
    • 51649111035 scopus 로고    scopus 로고
    • Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
    • Porkka K, Koskenvesa P, Lundan T, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood. 2008;112(4):1005-1012.
    • (2008) Blood , vol.112 , Issue.4 , pp. 1005-1012
    • Porkka, K.1    Koskenvesa, P.2    Lundan, T.3
  • 5
    • 70349915923 scopus 로고    scopus 로고
    • Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro
    • Amrein L, Panasci L, Gibson SB, Johnston JB, Soulieres D, Aloyz R. Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro. Br J Haematol. 2009;147(3):396-398.
    • (2009) Br J Haematol , vol.147 , Issue.3 , pp. 396-398
    • Amrein, L.1    Panasci, L.2    Gibson, S.B.3    Johnston, J.B.4    Soulieres, D.5    Aloyz, R.6
  • 6
    • 51649130092 scopus 로고    scopus 로고
    • The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes
    • Veldurthy A, Patz M, Hagist S, et al. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes. Blood. 2008;112(4):1443-1452.
    • (2008) Blood , vol.112 , Issue.4 , pp. 1443-1452
    • Veldurthy, A.1    Patz, M.2    Hagist, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.